Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PETER NOEL MATTAR

Allopathic & Osteopathic Physicians Family Medicine

NPI
1417005422
CMS profile
403151
Location
FONTANA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$80.88

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $80.88 4

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PETER NOEL MATTAR

NPI 1417005422 · CMS profile ID 403151

Allopathic & Osteopathic Physicians / Family Medicine

FONTANA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417005422?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PETER NOEL MATTAR, NPI 1417005422, CMS profile ID 403151. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417005422?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). PETER NOEL MATTAR, NPI 1417005422, CMS profile ID 403151. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417005422?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
PETER NOEL MATTAR, NPI 1417005422, CMS profile ID 403151, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1417005422?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $80.88 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biohaven Pharmaceutical Holding Company Ltd. $26.6012/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923665995 CMS
E.R. Squibb & Sons, L.L.C. $16.1810/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745387 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.1703/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923665993 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.9302/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887577781 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $118.47 7
PY2020 $145.56 8
PY2021 $538.51 27
PY2022 $80.88 4
PY2023 $144.88 6
PY2024 $349.01 12
PY2025 $392.79 17

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $340,972.86 20
PY2024 Principal investigator $1,031,028.37 17
PY2023 Recipient $1,403.27 3
PY2023 Principal investigator $150,709.11 12
PY2022 Principal investigator $12,739.12 12
PY2021 Principal investigator $147,126.46 20
PY2020 Principal investigator $1,000.00 1
PY2019 Principal investigator $580,983.06 21

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Organogenesis Inc. $13,487.00 11/30/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242005109
Principal investigator 1 Organogenesis Inc. $18,306.00 10/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004743
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,500.00 10/02/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Heterozygous Familial Hypercholesterolaemia No dispute reported 06/30/2026 1185540924
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,500.00 09/30/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event No dispute reported 06/30/2026 1185540922
Principal investigator 1 Organogenesis Inc. $39,514.50 09/30/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004515
Principal investigator 1 Organogenesis Inc. $1,448.40 09/30/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004522
Principal investigator 1 Organogenesis Inc. $1,072.89 09/30/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004529
Principal investigator 1 Organogenesis Inc. $16,078.50 08/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004271
Principal investigator 1 Organogenesis Inc. $614.25 08/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004276
Principal investigator 1 Organogenesis Inc. $33,054.75 07/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004001
Principal investigator 1 Organogenesis Inc. $9,855.00 07/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH - 2
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242004011
Principal investigator 1 Eli Lilly and Company $11,341.00 03/25/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF TIRZEPATIDE ON THE REDUCTION OF MORBIDITY AND MORTALITY IN ADULTS WITH OBESITY No dispute reported 06/30/2026 1187883040
Principal investigator 1 Organogenesis Inc. $675.00 02/28/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242002204
Principal investigator 1 Eli Lilly and Company $230.00 01/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH LLC
A STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND OBESITY OR OVERWEIGHT AT INCREASED CARDIOVASCULAR RISK (ACHIEVE-4) No dispute reported 06/30/2026 1187881204
Principal investigator 1 Eli Lilly and Company $325.00 01/31/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1187882058
Principal investigator 1 Eli Lilly and Company $3,033.07 01/27/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187883990
Principal investigator 1 Organogenesis Inc. $13,837.50 01/26/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
PREPARE PuraPly AM/XT No dispute reported 06/30/2026 1242001747
Principal investigator 1 Eli Lilly and Company $32,106.00 01/21/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1187882292
Principal investigator 1 Eli Lilly and Company $101,494.00 01/21/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187882850
Principal investigator 1 Organogenesis Inc. $9,500.00 01/02/2025 Non-covered Recipient Entity
INFINITY CLINICAL RESEARCH
20 VLU 003 AFF study No dispute reported 06/30/2026 1242001543